A Phase 1 Safety and Immunogenicity Study of the Epitope Based DNA Vaccine (EP HIV-1090) in HIV-1 Infected Individuals Receiving Antiretroviral Therapy (ART) (EP1090)
This study is ongoing, but not recruiting participants.
Study NCT00532974
Information provided by Epimmune
First Received: September 19, 2007
Last Updated: December 19, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
